Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M.P.H. Nadeem Q. Mirza M.D."'
Autor:
Merrick I. Ross, Barry W. Feig, L D O Richard Theriault, Funda Meric-Bernstam, Tina W. F. Yen, M.P.H. Nadeem Q. Mirza M.D., S. Eva Singletary, Thomas A. Buchholz, Frederick C. Ames, Eva S. Thomas, Kelly K. Hunt, Henry Mark Kuerer, Gildy V. Babiera
Publikováno v:
Cancer. 100:942-949
BACKGROUND To date, the impact of the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-24 trial reported in 1999 on the use of tamoxifen after surgery for ductal carcinoma in situ (DCIS) is unknown. The current study was designed to eval
Autor:
Massimo Cristofanilli, Jeannie Shen, Barry W. Feig, Frederick C. Ames, Merrick I. Ross, Gildy V. Babiera, Isabelle Bedrosian, Thomas A. Buchholz, M.P.H. Nadeem Q. Mirza M.D., Henry Mark Kuerer, Kelly K. Hunt, S. Eva Singletary, Funda Meric-Bernstam
Publikováno v:
Cancer. 104(3)
BACKGROUND In patients with breast carcinoma, ipsilateral breast tumor recurrence (IBTR) after breast-conserving therapy (BCT) is an independent predictor of systemic recurrence and disease-specific survival (DSS). However, only a subgroup of patient
Autor:
Funda Meric-Bernstam, Kelly K. Hunt, Henry Mark Kuerer, M.P.H. Nadeem Q. Mirza M.D., Gildy V. Babiera, Thomas A. Buchholz, Neslihan Cabioglu, S. Eva Singletary, Frederick C. Ames, Aysegul A. Sahin
Publikováno v:
Cancer. 104(1)
The risk of ipsilateral breast tumor recurrence (IBTR) after breast-conserving therapy (BCT) is associated with treatment and tumor-related variables, such as surgical margin status and the use of systemic therapy, and these variables have changed ov